Main Library
HHS aims to use value-based care payment models to lower drug prices

HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Robert KingNo CommentsFierce HealthcareAlternative payment models (APMs),Pharmacy Services,CMS, CMMI, Government, Policy & Regulations

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices.

The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms such as giving Medicare price negotiation authority and cap Part D catastrophic spending.

“By promoting negotiation, competition, and innovation in the health care industry, we will ensure cost fairness and protect access to care,” HHS Secretary Xavier Becerra said in a statement Thursday.

Full Article

: CMMI, drug prices, HHS, Pharmaceuticals

Related Posts

The digital divide becomes a new social determinant of health

February 22, 2021Garrett Schmitt

MedPAC: CMMI Should Consider a ‘Smaller, More Harmonized’ Portfolio of Alternative Payment Models

June 15, 2021Garrett Schmitt

Building A Value-Based Care Model in Life Sciences

March 28, 2018Garrett Schmitt

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • RECORDED WEBINAR: Beyond the Dashboard: Operationalizing Market Insights Across the Enterprise
  • A Strategic Guide for ACO Leaders: 3 Critical Considerations Before the August 1st CMS Deadline
  • RECORDED WEBINAR: Reducing Readmissions with Pharmacist-Led Medication Reconciliation for Safer Transitions of Care
  • RECORDED WEBINAR: CASE STUDY: How Privia Medical Group- North Texas and VillageMD Reduced Referral Leakage, Specialty, & Admin Costs
  • FLASH INTERVIEW – Symbion Coding Inc – 2025
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us